Browse by author
Lookup NU author(s): Professor Sanjay PandanaboyanaORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2016, The Society for Surgery of the Alimentary Tract.Introduction: This study analysed the effect of age on survival in patients undergoing major hepatectomy (MH) for colorectal liver metastases (CRLM). The effect of adjuvant chemotherapy (AC) with age was also assessed. Method: Patients undergoing MH for CRLM between 1996 and 2011 were reviewed. Patients aged <75 or ≥75 were compared for disease-free (DFS) and overall survival (OS) as well as impact of AC on survival. Results: Seven hundred twenty-seven patients underwent MH of which 105 (14 %) were aged ≥75. Morbidity was greater in the ≥75 group (25 versus 34 %, p = 0.048). No difference was noted in mortality. There was no difference in DFS between the two groups at 5 years (16.8 vs 18.9 months (p = 0.570). OS was longer in the <75 group (38.6 vs 32.0 months (p = 0.001). DFS was better in groups receiving AC than those not (<75 24.2 vs 12.2 months (p = <0.001) and ≥75 24 vs 12.1 months (p = 0.007)). OS in the ≥75 group was improved in the group receiving AC compared to the ≥75 group not (41.1 vs 16.6 months, p = 0.005). Age ≥75 was not an independent risk factor for reduced DFS on multivariate analysis. Conclusion: Well-selected patients aged ≥75 should be considered for MH followed by adjuvant chemotherapy.
Author(s): Bell R, Pandanaboyana S, Nisar S, Upasani V, Toogood G, Lodge JP, Prasad KR
Publication type: Article
Publication status: Published
Journal: Journal of Gastrointestinal Surgery
Year: 2017
Volume: 21
Issue: 2
Pages: 266-274
Print publication date: 01/02/2017
Online publication date: 21/10/2016
Acceptance date: 03/10/2016
ISSN (print): 1091-255X
ISSN (electronic): 1873-4626
Publisher: Springer New York LLC
URL: https://doi.org/10.1007/s11605-016-3296-7
DOI: 10.1007/s11605-016-3296-7
PubMed id: 27770289
Altmetrics provided by Altmetric
